Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros

Bases de dados
Assunto principal
País/Região como assunto
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
J Cutan Med Surg ; 23(5_suppl): 12S-18S, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31692377

RESUMO

Pediatric atopic dermatitis (AD) is one of the most common skin conditions encountered by health-care providers caring for infants, children, and adolescents. Pediatric patients with AD may present with other allergic and nonallergic comorbidities that require appropriate treatment and referral. They may also experience a trajectory of allergic diseases known as the atopic march, which depends on a complex interaction between genetic and environmental factors and likely involves early epidermal barrier dysfunction. Here we provide a review and clinical recommendations on the assessment and referral of comorbidities in pediatric AD.


Assuntos
Dermatite Atópica/epidemiologia , Criança , Comorbidade , Consenso , Humanos
2.
J Cutan Med Surg ; 23(5_suppl): 19S-31S, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31692376

RESUMO

Because atopic dermatitis (AD) is a chronic, relapsing disease, treatment requires the use of both active therapy to control flares and preventative maintenance therapy to promote integrity of the skin barrier. In this third of four sections, important clinical considerations for the treatment of pediatric AD are reviewed. Emerging therapies in development for pediatric AD are introduced.


Assuntos
Dermatite Atópica/terapia , Canadá , Criança , Humanos
3.
J Cutan Med Surg ; 23(5_suppl): 32S-39S, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31692378

RESUMO

This document is intended to provide practical guidance to physicians treating pediatric atopic dermatitis (AD), especially dermatologists, pediatricians, allergists, and other health-care professionals. The recommendations contained here were formalized based on a consensus of 12 Canadian pediatric dermatologists, dermatologists, pediatricians, and pediatric allergists with extensive experience managing AD in the pediatric population. A modified Delphi process was adopted with iterative voting on a 5-point Likert scale, with a prespecified agreement cutoff of 75%. Topic areas addressed in the 17 consensus statements reflect areas of practical management, including counselling, assessment, comorbidity management, and therapy.


Assuntos
Dermatite Atópica/epidemiologia , Canadá/epidemiologia , Criança , Comorbidade , Consenso , Humanos
4.
J Cutan Med Surg ; 23(5_suppl): 3S-11S, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31692379

RESUMO

Pediatric atopic dermatitis (AD) is one of the most common dermatoses encountered by health-care providers treating children. Diagnosis of AD is clinical, with no universally accepted biomarkers or assessment tools. Patient-reported outcomes and subjective assessments of quality of life in both the patient and family are important considerations when treating pediatric AD. Here, we provide an overview of pediatric AD epidemiology, its clinical presentation, burden, diagnosis, and assessment, with a focus on implications for patient counseling in order to optimize care.


Assuntos
Dermatite Atópica/diagnóstico , Dermatite Atópica/epidemiologia , Canadá/epidemiologia , Criança , Consenso , Efeitos Psicossociais da Doença , Humanos , Medidas de Resultados Relatados pelo Paciente , Qualidade de Vida
5.
J Cutan Med Surg ; 22(1_suppl): 3S-5S, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30439298

RESUMO

BACKGROUND:: Atopic dermatitis (AD) is a chronic, relapsing, and remitting inflammatory skin disease with complex pathophysiology, primarily driven by type 2 inflammation. Existing guidelines often do not reflect all current therapeutic options and guidance on the practical management of patients with AD is lacking. OBJECTIVES:: To develop practical, up-to-date guidance on the assessment and management of adult patients with AD. METHODS:: An expert panel of 17 Canadian experts, including 16 dermatologists and 1 allergist, with extensive clinical experience managing moderate-to-severe AD reviewed the available literature from the past 5 years using a defined list of key search terms. This literature, along with clinical expertise and opinion, was used to draft concise, clinically relevant reviews of the current literature. Based on these reviews, experts developed and voted on recommendations and statements to reflect the practical management of adult patients with AD as a guide for health care providers in Canada and across the globe, using a prespecified agreement cutoff of 75%. RESULTS:: Eleven consensus statements were approved by the expert panel and reflected 4 key domains: pathophysiology, assessment, comorbidities, and treatment. CONCLUSIONS:: These statements aim to provide a framework for the assessment and management of adult patients with AD and to guide health care providers in practically relevant aspects of patient management.


Assuntos
Dermatite Atópica/terapia , Adulto , Consenso , Humanos
6.
J Cutan Med Surg ; 22(1_suppl): 10S-16S, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30439297

RESUMO

Clinicians rely on clinical measures to define the severity of atopic dermatitis and assess outcomes of therapy. These measures can be objective (ie, physician assessments of disease severity) or subjective (ie, patient-reported symptoms and quality of life outcomes). In this review, the most commonly used tools for assessing atopic dermatitis severity in adult patients are presented and compared. These include Eczema Area and Severity Index (EASI); SCORing Atopic Dermatitis (SCORAD); Physician Global Assessment (PGA); body surface area (BSA); Atopic Dermatitis Severity Index (ADSI); Six Area, Six Sign Atopic Dermatitis (SASSAD); Patient Oriented Eczema Measure (POEM); Dermatology Life Quality Index (DLQI); and pruritus Numerical Rating Scale (NRS). Available severity strata for the tools are summarized, although the use of severity strata in clinical practice is not recommended. Since both objective and subjective assessments of disease severity are important to assess, consideration of clinical characteristics such as disease recurrence or persistence, as well as location of the affected areas, should be considered in the overall judgement of disease severity and consideration of therapy choice.


Assuntos
Dermatite Atópica/diagnóstico , Dermatite Atópica/fisiopatologia , Adulto , Consenso , Dermatite Atópica/terapia , Humanos , Medidas de Resultados Relatados pelo Paciente , Índice de Gravidade de Doença , Resultado do Tratamento
7.
J Cutan Med Surg ; 22(1_suppl): 30S-35S, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-30439300

RESUMO

This document is a concise, current, and practical guide for dermatologists and other health care providers managing adult patients with moderate-to-severe atopic dermatitis (AD). The recommendations made here are based on a consensus of specialists with extensive experience managing patients with AD. Topics reviewed in this publication include AD pathophysiology, assessment, comorbidities, and treatment options.


Assuntos
Dermatite Atópica/fisiopatologia , Dermatite Atópica/terapia , Adulto , Comorbidade , Consenso , Dermatite Atópica/epidemiologia , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA